Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BHBausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC)

New York Stock Exchange · Currency in USD
$6.44 ▼ -0.05 (-0.77%)
At close: Oct 23, 4:00 PM ET. Market closed.
$6.45 ▲ +0.01 (+0.13%)
After hours: Oct 23, 5:11 PM ET

Summary

Previous Close
$6.49
Open
$6.44
Day's Range
$6.20 – $6.49
52 Week Range
$4.33 – $8.00
Volume
2,400,625
Avg. Volume
3,083,779
Market Cap
$2.41B
Beta (5Y Monthly)
0.37
PE Ratio (TTM)
--
EPS (TTM)
-$2.93
Earnings Date
Oct 28, 2026
Forward Dividend & Yield
$4.00 (62.11%)
Ex-Dividend Date
Nov 10, 2010
1y Target Est
$9.00

Profile: Bausch Health Companies Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
20,300
CEO
Thomas J. Appio

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

Earnings

Next report: Wed, Oct 28, 2026
EPS estimate $1.25 · Revenue est. $2.72B
DateEst.Actual
Jul 29, 2026$0.96$1.26Beat
Apr 29, 2026$0.81$0.78Miss
Feb 18, 2026$1.21$1.08Miss
Oct 29, 2025$1.07$1.16Beat
Jul 30, 2025$0.97$0.90Miss
Apr 30, 2025$0.83$0.59Miss

Analyst view

Consensus price target
$9.00 ▲ +39.8%
Range $9.00 – $9.00
Rating: Buy
Buy 50% · Hold 39% · Sell 11%

Get free alerts on BHC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.